Tianjin Ringpu Bio Tech (300119) - Total Liabilities
Based on the latest financial reports, Tianjin Ringpu Bio Tech (300119) has total liabilities worth CN¥2.53 Billion CNY (≈ $370.32 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Tianjin Ringpu Bio Tech equity growth rate to track the company's year-over-year net asset growth rate.
Tianjin Ringpu Bio Tech - Total Liabilities Trend (2007–2025)
This chart illustrates how Tianjin Ringpu Bio Tech's total liabilities have evolved over time, based on quarterly financial data. See free cash flow generation of Tianjin Ringpu Bio Tech to measure how efficiently the company converts operating cash flow to free cash.
Tianjin Ringpu Bio Tech Competitors by Total Liabilities
The table below lists competitors of Tianjin Ringpu Bio Tech ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
NINGBO HENGSHUAI Co. LTD.
SHE:300969
|
China | CN¥595.89 Million |
|
Azenta Inc
NASDAQ:AZTA
|
USA | $349.21 Million |
|
TF Bank AB
ST:TFBANK
|
Sweden | Skr26.45 Billion |
|
MRC Global Inc
NYSE:MRC
|
USA | $1.26 Billion |
|
Bingo Software Co Ltd
SHG:688227
|
China | CN¥684.10 Million |
|
Shenzhen Hello Tech Energy Co. Ltd. A
SHE:301327
|
China | CN¥899.04 Million |
|
Iradimed Co
NASDAQ:IRMD
|
USA | $15.88 Million |
|
Asia Optical Co Inc
TW:3019
|
Taiwan | NT$10.68 Billion |
Liability Composition Analysis (2007–2025)
This chart breaks down Tianjin Ringpu Bio Tech's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Tianjin Ringpu Bio Tech (300119) total market value.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.81 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.53 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.32 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Tianjin Ringpu Bio Tech's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Tianjin Ringpu Bio Tech (2007–2025)
The table below shows the annual total liabilities of Tianjin Ringpu Bio Tech from 2007 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥2.47 Billion ≈ $361.63 Million |
-16.48% |
| 2024-12-31 | CN¥2.96 Billion ≈ $432.97 Million |
+65.20% |
| 2023-12-31 | CN¥1.79 Billion ≈ $262.09 Million |
+11.58% |
| 2022-12-31 | CN¥1.61 Billion ≈ $234.89 Million |
+17.41% |
| 2021-12-31 | CN¥1.37 Billion ≈ $200.05 Million |
+17.63% |
| 2020-12-31 | CN¥1.16 Billion ≈ $170.07 Million |
-3.64% |
| 2019-12-31 | CN¥1.21 Billion ≈ $176.50 Million |
+62.11% |
| 2018-12-31 | CN¥744.03 Million ≈ $108.88 Million |
-0.52% |
| 2017-12-31 | CN¥747.95 Million ≈ $109.45 Million |
+19.15% |
| 2016-12-31 | CN¥627.74 Million ≈ $91.86 Million |
+8.28% |
| 2015-12-31 | CN¥579.77 Million ≈ $84.84 Million |
+125.39% |
| 2014-12-31 | CN¥257.23 Million ≈ $37.64 Million |
-9.07% |
| 2013-12-31 | CN¥282.89 Million ≈ $41.40 Million |
+36.67% |
| 2012-12-31 | CN¥206.99 Million ≈ $30.29 Million |
+18.20% |
| 2011-12-31 | CN¥175.12 Million ≈ $25.63 Million |
-10.50% |
| 2010-12-31 | CN¥195.66 Million ≈ $28.63 Million |
+20.31% |
| 2009-12-31 | CN¥162.63 Million ≈ $23.80 Million |
+90.93% |
| 2008-12-31 | CN¥85.18 Million ≈ $12.46 Million |
+69.48% |
| 2007-12-31 | CN¥50.26 Million ≈ $7.35 Million |
-- |
About Tianjin Ringpu Bio Tech
Tianjin Ringpu Bio-Technology Co.,Ltd. engages in the research and development, production, and sale of veterinary raw materials, pharmaceutical preparation, functional additives, and veterinary biological products. The company provides vaccines, chemical drugs, traditional Chinese medicines; feed additives, including pigs, chickens, waterfowl, cattle, sheep and pet medicines, and vaccines; and p… Read more